Entest Biomedical Inc (ENTB.PK)

ENTB.PK on OTC Markets Group

18 Dec 2014
Price Change (% chg)

-- (--)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low


Chart for ENTB.PK


Entest BioMedical, Inc. (Entest) is a development-stage company. During the fiscal year ended August 31, 2012, the Company’s business consists of the development and commercialization of immunotherapeutic therapies for the veterinary market, as well as the acquisition and operation of veterinary hospitals. The Company is... (more)
No analyst recommendations are available for ENTB.PK.


Beta: 3.42
Market Cap (Mil.): $0.24
Shares Outstanding (Mil.): 2,405.57
Dividend: --
Yield (%): --


  ENTB.PK Industry Sector
P/E (TTM): -- 26.33 38.03
EPS (TTM): -0.00 -- --
ROI: -- 7.72 18.26
ROE: -- 11.98 19.16
Search Stocks

Earnings vs. Estimates

No consensus analysis data available.

Analyst Research Reports

Report Title Price
Provider: Wright Reports
Provider: Reuters Investment Profile
Provider: GlobalData
Provider: GlobalData

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks